| 2026 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2026
|
| |
– |
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2026 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2026
|
| 2025 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2025
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2025 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2025
|
| 2025 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2025
|
| |
– |
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2025 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2025
|
| 2024 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2024
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2024 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2024
|
| 2024 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2024
|
| |
– |
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2024 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2024
|
| |
| 2023 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2023
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2023 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2023
|
| 2023 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2023
|
| |
– |
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2023 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2023
|
| |
| 2022 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2022
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2022 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2022
|
| 2022 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2022
|
| |
– |
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2022 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2022
|
| |
| 2021 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2021
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2021 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2021
|
| 2021 Q2 |
– |
Regulatory Disclosure Statement for the Position Date of 30 June 2021
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| 2021 Q1 |
– |
Regulatory Disclosure Statement for the Position Date of 31 March 2021
|
| 2020 Q4 |
– |
Regulatory Disclosure Statement for the Position Date of 31 December 2020 |
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
|
2020 Q3
|
–
|
Regulatory Disclosure Statement for the Position Date of 30 September 2020
|
|
2020 Q2
|
–
|
Regulatory Disclosure Statement for the Position Date of 30 June 2020
|
|
|
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2020 Q1
|
–
|
Regulatory Disclosure Statement for the Position Date of 31 March 2020
|
|
2019 Q4
|
–
|
Regulatory Disclosure Statement for the Position Date of 31 December 2019
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
| 2019 Q3 |
– |
Regulatory Disclosure Statement for the Position Date of 30 September 2019
|
|
2019 Q2
|
–
|
Regulatory Disclosure Statement for the Position Date of 30 June 2019
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2019 Q1
|
–
|
Quarterly Disclosures
|
|
2018 Q4
|
–
|
Annual Disclosures
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Key Elements of Disclosure Policy
|
|
2018 Q3
|
–
|
Quarterly Disclosures
|
|
2018 Q2
|
–
|
Semi-annual Disclosures
|
| |
–
|
Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2018 Q1
|
–
|
First Quarter Disclosures
|
|
2017 Q4
|
–
|
Annual Disclosures on Regulatory Capital
|
| |
–
|
Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Annual Disclosures on Leverage Ratio
|
| |
–
|
Annual Disclosures on Pillar 3
|
| |
–
|
Key Elements of Disclosure Policy
|
|
2017 Q3
|
–
|
Third Quarter Disclosures on Pillar 3
|
|
2017 Q2
|
–
|
Interim Disclosures on Regulatory Capital
|
| |
–
|
Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Interim Disclosures on Leverage Ratio
|
| |
–
|
Interim Disclosures on Pillar 3
|
|
2017 Q1
|
–
|
First Quarter Disclosures on Pillar 3
|
|
2016 Annual
|
–
|
Annual Disclosures on Regulatory Capital
|
| |
–
|
Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Annual Disclosures on Leverage Ratio
|
|
2016 Interim
|
–
|
Interim Disclosures on Regulatory Capital
|
| |
–
|
Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Interim Disclosures on Leverage Ratio
|
|
2015 Annual
|
–
|
Annual Disclosures on Regulatory Capital
|
| |
–
|
Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Annual Disclosures on Leverage Ratio
|
|
2015 Interim
|
–
|
Interim Disclosures on Regulatory Capital
|
| |
–
|
Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
| |
–
|
Interim Disclosures on Leverage Ratio
|
|
2014 Annual
|
–
|
Annual Disclosures on Regulatory Capital
|
| |
–
|
Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2014 Interim
|
–
|
Interim Disclosures on Regulatory Capital
|
| |
–
|
Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2013 Annual
|
–
|
Annual Disclosures on Regulatory Capital
|
| |
–
|
Annual Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
|
2013 Interim
|
–
|
Interim Disclosures on Regulatory Capital
|
| |
–
|
Interim Disclosures on Terms and Conditions of the Capital Instruments Issued (Common Shares - Ordinary Share Capital)
|
